InsidersTradesSigma
Follow the 아리바이오LAB share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Market capitalisation: €263.7m. The latest transaction was disclosed on 15 July 2026 (Other). Among the most active insiders: 아리바이오LAB. Every trade is accessible without an account.
Analysts rate 아리바이오LAB Hold (neutral), based on 1 analysts. Average price target: US$1.35.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
AribioLAB es una empresa que cotiza en el mercado XKRX, especializada en el desarrollo de soluciones biofarmacéuticas. Se centra en la investigación y la innovación en el sector de la salud.